The clinical characteristics and the response to treatment with high doses of co-trimoxazole in 12 children with brucellar arthritis were analysed retrospectively. The children lived in an urban area and all but two had a history of unprocessed milk or cheese ingestion. Fever and oligoarthritis of the lower extremities were the most common clinical findings. Control of the disease was achieved by three months of treatment. Compliance with the medication was excellent, and no significant side effects occurred.
arthritis.' Treatment includes the long term use of tetracycline and streptomycin. In children this form of therapy is limited by side effects and toxicity. Recently, successful control of the disease in adults with co-trimoxazole has been reported.2 3 Over a four year period we have seen 12 children with brucellar arthritis and have treated them with high doses of co-trimoxazole. In this report we describe our experiences with this group of patients.
Patients and methods
We reviewed the records of 12 children with brucellar arthritis attending our Paediatric Rheumatology Unit between January 1979 and December 1982. Particular attention was paid to a previous history of ingestion of unprocessed dairy products or contact with cattle, presenting features, musculoskeletal symptoms and signs, and the response to therapy. Laboratory tests reviewed included full Accepted for publication 13 The interval between onset of symptoms and diagnosis ranged from five days to two years. Patients with hip involvement had the longest delay (> five months). Systemic signs and symptoms were absent except for fever (> 38-5°C) in seven patients. All had arthritis and six had arthralgias related to non-inflamed joints (Table 1 ). The arthritis was characterised mostly by soft tissue swelling without obvious effusions. A total of 21 joints were inflamed (Table 1) . Hips, elbows, and knees were often involved, while small joints of the hands, feet, and spine were never affected.
Routine laboratory investigations were unremarkable. Eleven patients had normal blood counts and one eosinophilia. The erythrocyte sedimentation rate was raised (>20 mm/lst h) in six patients. (Table 2) . Radiographic studies showed narrowing of the joint space in two hips and one sacroiliac joint, juxta-articular osteopenia in one elbow, and soft tissue swelling in the remaining joints.
All patients were treated orally for 12 weeks with co-trimoxazole (Table 3) . Eleven were followed up for a minimum of two years and one was lost to follow up after six months. The therapeutic response was good, the arthritis subsiding within two to three months in all. Two patients with hip involvement, however, still have functional limitation of the joint. Relapses of the disease were not seen. Compliance with the medication was excellent, and no side effects were seen or reported. 
